NCT06691841

Brief Summary

Evaluation of the application effect of compound chlorhexidine gargle in oral care of patients with endotracheal intubation based on 16s RNA technology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

September 23, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
9 months until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
Last Updated

November 15, 2024

Status Verified

September 1, 2024

Enrollment Period

8 months

First QC Date

September 23, 2022

Last Update Submit

November 14, 2024

Conditions

Keywords

Chlorhexidine GluconateEndotracheal Intubation16sRNA

Outcome Measures

Primary Outcomes (1)

  • Changes in the oral microbiota

    objective analysis results based on 16s RNA technology

    Immediately after enrollment; 48 hrs after intubation;5 days after intubation

Secondary Outcomes (4)

  • oral complications

    mechanical ventilation at 0 hours, 2 days, and 5 days post-intervention

  • plaque Index

    mechanical ventilation at 0 hours, 2 days, and 5 days post-intervention

  • whether VAP occurs

    Immediately after enrollment; 48 hrs after intubation;5 days after intubation

  • 28-day mortality rate

    28 days post-randomization

Study Arms (2)

Normal Saline Group

OTHER

oral wiping and oral care solution rinsing, oral care solution was 0.9% normal saline, and oral care frequency was 3 times a day.

Other: normal saline

Chlorhexidine group

EXPERIMENTAL

oral wiping and oral care solution rinsing, oral care solution was 0.12% Chlorhexidine gluconate solution, and oral care frequency was 3 times a day.

Drug: Chlorhexidine Gluconate

Interventions

oral wiping and oral care solution rinsing, oral care solution was 0.12% chlorhexidine gluconate, and the frequency of oral care was 3 times a day.

Also known as: jinkouxin
Chlorhexidine group

oral wiping and oral care solution rinsing, oral care solution was 0.9% normal saline, and the frequency of oral care was 3 times a day.

Normal Saline Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years; ② Complete clinical data; ③ Expected duration of orotracheal intubation for mechanical ventilation exceeding 5 days.

You may not qualify if:

  • Patients with abnormal coagulation function, severe respiratory burns, oral surgery, lung and systemic infections; ② Patients expected to die within 48 hours after extubation; ③ Patients with actual duration of orotracheal intubation for mechanical ventilation less than 5 days.
  • Failure to follow the prescribed plan; ② Incomplete data; ③ Patients who voluntarily withdraw from treatment during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changcui Qiu

Shanghai, 200072, China

Location

Related Publications (1)

  • Qiu C, Tang L, Hang Z, Wei K, Wang S, Zhu X, Wang Q. Effect of chlorhexidine vs. saline for oral care on oral microbiota and prognosis of elderly mechanically ventilated patients in the intensive care unit: a single-center, single-blind, randomized controlled trial. BMC Oral Health. 2025 Dec 28. doi: 10.1186/s12903-025-07579-7. Online ahead of print.

MeSH Terms

Interventions

chlorhexidine gluconateSaline Solution

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • sheng wang, PHD

    Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

September 23, 2022

First Posted

November 15, 2024

Study Start

September 1, 2022

Primary Completion

May 1, 2023

Study Completion

March 1, 2024

Last Updated

November 15, 2024

Record last verified: 2024-09

Locations